Showing 2,001 - 2,020 results of 48,330 for search '(( 50 ((nn decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 12 we decrease ))', query time: 0.58s Refine Results
  1. 2001
  2. 2002
  3. 2003
  4. 2004

    Inhibitory dose of CAP (ID<sub>50</sub>). by Alan Siu (756300)

    Published 2015
    “…<p>Duration of CAP treatment necessary to decrease viability by 50%, termed the inhibitory duration (ID<sub><b>50</b></sub>). …”
  5. 2005
  6. 2006
  7. 2007
  8. 2008

    Typical structure of a centrifugal nozzle [25]. by Yanyu Cui (19173181)

    Published 2025
    “…As temperature rises from 0°C to 50°C, liquid film thickness decreases, with a reduction of 14.6% for low-blending fuel and 52.8% for high-blending fuel.…”
  9. 2009
  10. 2010
  11. 2011
  12. 2012
  13. 2013
  14. 2014
  15. 2015

    Discovery of Selective Dopamine Receptor Ligands Derived from (−)-Stepholidine via C‑3 Alkoxylation and C‑3/C‑9 Dialkoxylation by Hari K. Namballa (13363787)

    Published 2023
    “…A C-9 ethoxyl substituent appears optimal for D1R affinity since high D1R affinities were observed for compounds that contain an ethyl group at C-9, with larger C-9 substituents tending to decrease D1R affinity. A number of novel ligands were identified, such as compounds <b>12a</b> and <b>12b</b>, with nanomolar affinities for D1R and no affinity for either D2R or D3R, with compound <b>12a</b> being identified as a D1R antagonist for both G-protein- and β-arrestin-based signaling. …”
  16. 2016

    Discovery of Selective Dopamine Receptor Ligands Derived from (−)-Stepholidine via C‑3 Alkoxylation and C‑3/C‑9 Dialkoxylation by Hari K. Namballa (13363787)

    Published 2023
    “…A C-9 ethoxyl substituent appears optimal for D1R affinity since high D1R affinities were observed for compounds that contain an ethyl group at C-9, with larger C-9 substituents tending to decrease D1R affinity. A number of novel ligands were identified, such as compounds <b>12a</b> and <b>12b</b>, with nanomolar affinities for D1R and no affinity for either D2R or D3R, with compound <b>12a</b> being identified as a D1R antagonist for both G-protein- and β-arrestin-based signaling. …”
  17. 2017
  18. 2018
  19. 2019
  20. 2020